Overview of Dr. Faleck
Dr. David Faleck is a gastroenterologist in New York, NY and is affiliated with multiple hospitals in the area, including Memorial Sloan Kettering Cancer Center and Memorial Hospital for Cancer and allied Diseases. He received his medical degree from Albert Einstein College of Medicine of Yeshiva University and has been in practice 5 years. He is one of 35 doctors at Memorial Sloan Kettering Cancer Center and one of 3 doctors at Memorial Hospital for Cancer and allied Diseases who specialize in Gastroenterology. He has more than 40 publications and over 500 citings.
Office
160 East 53rd Street
New York, NY 10022
Education & Training
- Icahn School of Medicine at Mount Sinai/Mount Sinai HospitalFellowship, Gastroenterology, 2015 - 2018
- New York Presbyterian Hospital (Columbia Campus)Residency, Internal Medicine, 2012 - 2015
- Albert Einstein College of MedicineClass of 2012
- University of PennsylvaniaBA, Biology, Jewish Studies, summa cum laude, 2004 - 2008
Certifications & Licensure
- FL State Medical License 2021 - Present
- NY State Medical License 2015 - 2026
- CT State Medical License 2024 - 2025
- NJ State Medical License 2022 - 2025
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Gastroenterology
Awards, Honors, & Recognition
- Member AOA, 2012
- Member Phi Beta Kappa, 2007
Clinical Trials
- Stool Transplant to Control Treatment-related Diarrhea Start of enrollment: 2021 May 10
Publications & Presentations
PubMed
- Safety of Immunosuppression in a Prospective Cohort of Inflammatory Bowel Disease Patients With a HIstoRy of CancEr: SAPPHIRE Registry.Steven H Itzkowitz, Yue Jiang, Cristina Villagra, Jean-Frederic Colombel, Keith Sultan
Clinical Gastroenterology and Hepatology. 2025-04-01 - Baseline colitogenicity and acute perturbations of gut microbiota in immunotherapy-related colitis.Joan Shang, Diane Marie Del Valle, Graham J Britton, K R Mead, Urvija Rajpal
The Journal of Experimental Medicine. 2025-01-06 - 2 citationsImmune Checkpoint Inhibitor-Induced Colitis.Anusha S Thomas, Yang Lu, Mathew Campbell, John A Thompson, Dongfeng Tan
Gastroenterology. 2025-01-01
Journal Articles
- Correction: Vedolizumab for Ulcerative Colitis: Treatment Outcomes from the VICTORY ConsortiumLeah Katta, Robert Hirten, Shannon Chang, Dana Lukin, Edward V Loftus, David Faleck, Arun Swaminath, William J Sandborn, Sashidhar Varma Sagi, Sunanda Kane, Prianka Ch..., Nature
- Vedolizumab for Ulcerative Colitis: Treatment Outcomes from the VICTORY ConsortiumGursimran Kochhar, Justin Hartke, Sashidhar Varma Sagi, Edward V Loftus, Joseph Meserve, Robert Hirten, David Faleck, Shannon Chang, Dana Lukin, Farhad Peerani, Leah K..., Nature
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: